Risultati di ricerca
2 giorni fa · Mordecai Wayne. Citazione di: Azrael il 08 Agosto 2022, 09:07:19 Human Target VOL.1 - Un Delicato StratagemmaDC Black Label Complete Collection Autori: Tom King, Greg Smallwood 17X26, C., 192 pp., col.|23€ Contiene: The Human Target (2021) #1/6 DC PANINI COMICS • Christopher Chance è abituato a fare da bersaglio umano, come vocazione ...
5 giorni fa · Open Targets is an innovative, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. Visit the Open Targets Platform which integrates public domain data to enable target identification and prioritisation, or Open Targets Genetics ...
1 giorno fa · Here the authors isolate two human antibodies, H7.HK1 and H7.HK2, that achieve broad and potent neutralization against H7N9 influenza by targeting a distinct lateral patch on the hemagglutinin ...
5 giorni fa · After combining the data from RIP-seq of the human testis with those from PAR-CLIP-seq of DAOY cells, 392 overlapped DAZ target transcripts were identified (Figure 5b). Gene Ontology analysis showed that these genes were highly enriched in the “cell cycle” and “translation” pathways, consistent with the PAR-CLIP-seq results in DAOY cells (Figure 5c ).
3 giorni fa · Target identification is the process of identifying the direct molecular target – for example protein or nucleic acid – of a small molecule. In clinical pharmacology, target identification is...
2 giorni fa · Each human cell contains approximately 100 mitochondria, giving a total number of mtDNA molecules per human cell of approximately 500. However, the amount of mitochondria per cell also varies by cell type, and an egg cell can contain 100,000 mitochondria, corresponding to up to 1,500,000 copies of the mitochondrial genome (constituting up to 90% of the DNA of the cell).
5 giorni fa · This first-in-human phase 0 trial uses an 111In-radiolabeled anti-hK2 monoclonal antibody, [111In]-DOTA-h11B6, to credential hK2 as a potential target for prostate cancer treatment. Methods: Participants with progressive mCRPC received a single infusion of 2 mg of [111In]-DOTA-h11B6 (185 MBq of 111In), with or without 8 mg of unlabeled h11B6 to assess antibody mass effects.
